Smith & Nephew, Inc.
NYSE SNN · Watford, Hertfordshire, United Kingdom
Works in Cardiovascular · Dermatology · ENT · Genetic & rare · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Respiratory
Smith & Nephew, Inc. is a clinical trial sponsor based in Watford, Hertfordshire, United Kingdom, listed as NYSE SNN. It has 22 active clinical trials with 5,119 planned participants, across 9 therapeutic areas. Since 2021 it has completed 44 trials and stopped 24 early.
Trial track record · since 2021
Financials · NYSE SNN
Fundraising
Pipeline · 22 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Smith & Nephew, Inc
Smith & Nephew, Inc is lead sponsor of 22 active clinical trials on ClinicalTrials.gov, with 5,119 planned participants, in Cardiovascular, Dermatology, ENT, Genetic & rare and other areas. Since 2021 it has completed 44 trials and stopped 24 early.
Smith & Nephew, Inc is based in Watford, Hertfordshire, United Kingdom and is listed as NYSE SNN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Smith & Nephew, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-08.
Approve Suite is not affiliated with Smith & Nephew, Inc.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.